BCR / C. R. Bard, Inc. - Corporate Bond/Note - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

BCR / Bard (C.R.), Inc. 15-12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-06926 C. R. BARD INC. (Exact name of registrant as specified in its cha

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS 1 d515623ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-205849 Registration No. 333-197914 Registration No. 333-189705 Registration No. 333-182239 Registration No. 333-167576 Registration No. 333-159928 Registration No. 333-151740 Registration No. 333-135098 Registration No. 333-114947 Registration No. 333-104683 Registrati

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS 1 d515623ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-205849 Registration No. 333-197914 Registration No. 333-189705 Registration No. 333-182239 Registration No. 333-167576 Registration No. 333-159928 Registration No. 333-151740 Registration No. 333-135098 Registration No. 333-114947 Registration No. 333-104683 Registrati

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS 1 d515623ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-205849 Registration No. 333-197914 Registration No. 333-189705 Registration No. 333-182239 Registration No. 333-167576 Registration No. 333-159928 Registration No. 333-151740 Registration No. 333-135098 Registration No. 333-114947 Registration No. 333-104683 Registrati

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

BCR / Bard (C.R.), Inc. S-8 POS

S-8 POS 1 d515623ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-205849 Registration No. 333-197914 Registration No. 333-189705 Registration No. 333-182239 Registration No. 333-167576 Registration No. 333-159928 Registration No. 333-151740 Registration No. 333-135098 Registration No. 333-114947 Registration No. 333-104683 Registrati

BCR / Bard (C.R.), Inc. POSASR

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

Fifth Supplemental Indenture, dated December 28, 2017, between C. R. Bard, Inc. and Wells Fargo Bank, National Association, as trustee

EX-4.1 Exhibit 4.1 C. R. BARD, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE FIFTH SUPPLEMENTAL INDENTURE Dated as of December 28, 2017 To the Indenture dated as of December 20, 2010 3.000% Notes due 2026 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 2 Section 1.1 Definitions 2 ARTICLE 2 AMENDMENTS 2 Section 2.1 Certain Amendments to the Indenture 2 ARTICLE 3 EFFECTIVENESS 4 Section 3

BD COMPLETES BARD ACQUISITION, CREATING NEW GLOBAL HEALTH CARE LEADER

EX-99.1 Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE Contacts: Troy Kirkpatrick Monique N. Dolecki BD Public Relations BD Investor Relations 858.617.2361 201.847.5378 [email protected] [email protected] BD COMPLETES BARD ACQUISITION, CREATING NEW GLOBAL HEALTH CARE LEADER FRANKLIN LAKES, N.J., Dec. 29, 2017 ? BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical tec

Restated Certificate of Incorporation of C. R. Bard, Inc.

EX-3.1 Exhibit 3.1 RESTATED CERTIFICATE OF INCORPORATION OF C. R. BARD, INC. Pursuant to the provisions of Sections 14A:9-5 and 14A:10-1 of the New Jersey Business Corporation Act, the undersigned Corporation hereby executes the following Restated Certificate of Incorporation: FIRST: The name of the corporation is C. R. Bard, Inc. (the ?Corporation?). SECOND: The purpose for which the Corporation

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2017 (December 28, 2017) C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorp

Amended and Restated Bylaws of C. R. Bard, Inc.

EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF C. R. BARD, INC. (a New Jersey corporation) ARTICLE I SHAREHOLDERS 1. CERTIFICATES REPRESENTING STOCK. (a) Certificates representing stock in the Corporation shall be signed by, or in the name of, the Corporation by the Chairperson or Vice-Chairperson of the Board of Directors, if any, or by the President or a Vice-President and may be countersigne

EX-99.25

EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 9, 2018, pursuant to the provisions of Rule 12d2-2 (a). [ X ] 17 CFR 240.12d2

Omnibus Amendment to Terms and Conditions of Restricted Stock Units Awards under the Company’s 2012 Long Term Incentive Plan (as Amended and Restated), effective August 2, 2017**

EX-10.49 EXHIBIT 10.49 OMNIBUS AMENDMENT TO TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS AWARDS This Omnibus Amendment to the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated) (the “Plan”) Restricted Stock Units Terms and Conditions (Performance Vesting) (the “RSU Terms and Conditions”) is effective as of August 2, 2017 (the “Amendment Date”) and applies to all RSU Term

Omnibus Amendment to Terms and Conditions of Management Stock Purchase Program Awards (2015 and later) under the Company’s 2012 Long Term Incentive Plan (as Amended and Restated), effective August 2, 2017**

EX-10.48 EXHIBIT 10.48 OMNIBUS AMENDMENT TO TERMS AND CONDITIONS OF MANAGEMENT STOCK PURCHASE PROGRAM AWARDS (2015 AND LATER) This Omnibus Amendment to the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated) Management Stock Purchase Program Elective and Premium Share Units Terms and Conditions (the “MSPP”) is effective as of August 2, 2017 (the “Amendment Date”) and relate

Omnibus Amendment to Terms and Conditions of Performance Long-Term Incentive Awards under the Company’s 2012 Long Term Incentive Plan (as Amended and Restated), effective August 2, 2017**

EX-10.50 EXHIBIT 10.50 OMNIBUS AMENDMENT TO TERMS AND CONDITIONS OF PERFORMANCE LONG-TERM INCENTIVE PLAN AWARDS This Omnibus Amendment to the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated) Performance Long-Term Incentive Award Terms and Conditions (the “PLTIP”) is effective as of August 2, 2017 (the “Amendment Date”). 1. Section 1(h) of the PLTIP is amended and restate

Omnibus Amendment to Terms and Conditions of Management Stock Purchase Program Awards (2014 and earlier) under the Company’s 2012 Long Term Incentive Plan (as Amended and Restated), effective August 2, 2017**

EX-10.47 EXHIBIT 10.47 OMNIBUS AMENDMENT TO TERMS AND CONDITIONS OF MANAGEMENT STOCK PURCHASE PLAN AWARDS (2014 AND EARLIER) This Omnibus Amendment to the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated) Management Stock Purchase Program Elective and Premium Share Units Terms and Conditions (the “MSPP”) is effective as of August 2, 2017 (the “Amendment Date”) and relates

Amendment to C. R. Bard, Inc. Supplemental Executive Retirement Plan, effective August 2, 2017**

EX-10.46 EXHIBIT 10.46 AMENDMENT TO SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN This Amendment to the Supplemental Executive Retirement Plan (Amended and Restated as of December 31, 2007) (the “Plan”) is effective as of August 2, 2017 (the “Amendment Date”). 1. The third paragraph of Section 5.8 of the Plan is amended and restated in its entirety, effective as of the Amendment Date, to read as follows:

Omnibus Amendment to the Deferred Compensation Contract, Deferral of Directors’ Fees of C. R. Bard, Inc., effective August 2, 2017**

EX-10.51 EXHIBIT 10.51 Omnibus Amendment to the Deferred Compensation Contract Deferral of Directors’ Fees This Omnibus Amendment to the Deferred Compensation Contract Deferral of Directors’ Fees agreements entered into between C. R. Bard, Inc. and numerous directors (the “Agreements”) is effective as of August 2, 2017 (the “Amendment Date”). 1. Section 1.02 of the Agreements is amended and restat

Computation of Ratio of Earnings to Fixed Charges**

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Nine Months Ended September 30, 2017 Years Ended December 31, 2016 2015 2014 2013 2012 (dollars in millions) Earnings from operations before taxes $ 485.7 $ 663.7 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 Add (Deduct): Fixed charges 51.6 63.2 52.8 52.9 52.4 46.1 Undistributed earnings of

BCR / Bard (C.R.), Inc. 10-Q (Quarterly Report)

10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

BARD ANNOUNCES THIRD QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES THIRD QUARTER RESULTS MURRAY HILL, NJ ? (October 25, 2017) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial da

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commission

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2017 (August 8, 2017) C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorpo

BARD SHAREHOLDERS APPROVE PROPOSED MERGER WITH BECTON, DICKINSON

EX-99.1 Exhibit 99.1 Bard Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BD Contacts: Investor Relations: Monique N. Dolecki, Vice President, Investor Relations (201) 847-5378 Media Relations: Kristen Cardillo Vice President, Global Communication (201) 847-5657 BARD SHAREHOLD

BARD SHAREHOLDERS APPROVE PROPOSED MERGER WITH BECTON, DICKINSON

EX-99.1 Exhibit 99.1 Bard Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BD Contacts: Investor Relations: Monique N. Dolecki, Vice President, Investor Relations (201) 847-5378 Media Relations: Kristen Cardillo Vice President, Global Communication (201) 847-5657 BARD SHAREHOLD

Bard (C.R.) FORM 8-K (Prospectus)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2017 (August 8, 2017) C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorpo

Becton, Dickinson 425 (Prospectus)

425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 SUBJECT COMPANY: C.

Bard (C.R.) DEFA14A

DEFA14A 1 d431924ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☑ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

8-K 1 d431924d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2017 (July 28, 2017) C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey (State or other jurisdiction of incorpor

Amendment No. 1, dated July 28, 2017, to the Agreement and Plan of Merger, dated April 23, 2017, by and among C. R. Bard, Inc., Becton Dickinson and Company and Lambda Corp. (incorporated by reference to Exhibit 2.1 to Bard’s Current Report on Form 8-K on July 28, 2017)

EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER This Amendment No. 1 (this ?Amendment?) to the Agreement and Plan of Merger, dated as of April 23, 2017 (the ?Merger Agreement?), by among C. R. Bard, Inc., a New Jersey corporation (the ?Company?), Becton, Dickinson and Company, a New Jersey corporation (?Parent?), and Lambda Corp., a New Jersey corporation and a

Bard (C.R.) FORM 8-K (Prospectus)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2017 (July 28, 2017) C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey (State or other jurisdiction of incorporation) 001-6926 (Comm

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER

EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER This Amendment No. 1 (this ?Amendment?) to the Agreement and Plan of Merger, dated as of April 23, 2017 (the ?Merger Agreement?), by among C. R. Bard, Inc., a New Jersey corporation (the ?Company?), Becton, Dickinson and Company, a New Jersey corporation (?Parent?), and Lambda Corp., a New Jersey corporation and a

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER

EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER This Amendment No. 1 (this ?Amendment?) to the Agreement and Plan of Merger, dated as of April 23, 2017 (the ?Merger Agreement?), by among C. R. Bard, Inc., a New Jersey corporation (the ?Company?), Becton, Dickinson and Company, a New Jersey corporation (?Parent?), and Lambda Corp., a New Jersey corporation and a

Becton, Dickinson FORM 8-K (Prospectus)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): July 28, 2017 (July 28, 2017) BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other jurisdic

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Six Months Ended June 30, 2017 Years Ended December 31, 2016 2015 2014 2013 2012 (dollars in millions) Earnings from operations before taxes $ 370.3 $ 663.7 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 Add (Deduct): Fixed charges 34.6 63.2 52.8 52.9 52.4 46.1 Undistributed earnings of equit

BCR / Bard (C.R.), Inc. 10-Q (Quarterly Report)

10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

BARD ANNOUNCES SECOND QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES SECOND QUARTER RESULTS MURRAY HILL, NJ ? (July 27, 2017) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2017 second quarter financial results. Second quarter 2017 net sales were $979.7 million,

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 d432028d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorpora

Bard (C.R.) 425 (Prospectus)

425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Registration File No. 333-218179 On July 18, 2017, C. R. Bard, Inc. (?Bard?) made the following letter available to shareholders of Bard in connection with Becton, Dickinson and Company?s pending acquisition of B

Bard (C.R.) DEFM14A

DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Bard (C.R.) 11-K

11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ? TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-6926 A.

BD and Bard Receive Second Requests from FTC under HSR Act Companies continue to expect the transaction to close in the fall of 2017

EX-99.1 Exhibit 99.1 Contacts: Monique N. Dolecki Todd W. Garner BD Investor Relations Bard Investor Relations 201.847.5378 908.277.8065 [email protected] [email protected] Kristen Cardillo Scott T. Lowry BD Corporate Communication Bard Media Relations 201.84.5657 908.277.8365 [email protected] [email protected] BD and Bard Receive Second Requests from FTC under HSR Act Compani

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commission

Bard (C.R.) FORM 8-K (Prospectus)

425 1 d377192d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incor

BD and Bard Receive Second Requests from FTC under HSR Act Companies continue to expect the transaction to close in the fall of 2017

EX-99.1 Exhibit 99.1 Contacts: Monique N. Dolecki Todd W. Garner BD Investor Relations Bard Investor Relations 201.847.5378 908.277.8065 [email protected] [email protected] Kristen Cardillo Scott T. Lowry BD Corporate Communication Bard Media Relations 201.84.5657 908.277.8365 [email protected] [email protected] BD and Bard Receive Second Requests from FTC under HSR Act Compani

Bard (C.R.) 425 (Prospectus)

425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 On May 25, 2017, C. R. Bard, Inc. (?Bard?) made the following letter available to employees of Bard in connection with Becton, Dickinson and Company?s pending acquisition of Bard. To

Becton, Dickinson FORM 425 (Prospectus)

425 1 s001721x1425.htm FORM 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 SUBJECT COMPANY: C.R. BARD, INC. SEC FILE NO.: 001-06926 DATE: MAY 25, 2017 On May 25, 2017, the following communication was sent to employees of C. R. Bard, Inc. by Vincent Forlenza, Chai

Becton, Dickinson and Company Debt Securities Underwriting Agreement May 22, 2017

Exhibit 1.1 EXECUTION VERSION Becton, Dickinson and Company Debt Securities Underwriting Agreement May 22, 2017 Citigroup Global Markets Inc. BNP Paribas Securities Corp. Barclays Capital Inc. MUFG Securities Americas Inc. Wells Fargo Securities, LLC As Representatives of the several Underwriters c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 Ladies and Gentlemen:

Becton, Dickinson and Company Debt Securities Underwriting Agreement

Exhibit 1.2 EXECUTION VERSION Becton, Dickinson and Company Debt Securities Underwriting Agreement May 23, 2017 Barclays Bank PLC BNP Paribas Citigroup Global Markets Limited Scotiabank Europe plc Standard Chartered Bank U.S. Bancorp Investments, Inc. BNY Mellon Capital Markets, LLC ING Bank N.V., Belgian Branch Loop Capital Markets LLC The Williams Capital Group, L.P. Ladies and Gentlemen: Becton

Title of Series/CUSIP Number of Bard Notes to be Exchanged

Exhibit 99.1 Press Release BD Announces Results of Early Tenders and Amendments to Exchange Offers FRANKLIN LAKES, N.J., May 19, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that, in connection with its previously announced offers to exchange (the ?Exchange Offers?) any and all outstanding 4.400% Notes due 2021, 3.000% Notes due 2026 and 6.700% Notes due 2026 (collectively

Becton, Dickinson FORM 8-K (Prospectus)

425 1 s001681x68k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): May 19, 2017 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other jur

C. R. BARD, INC. THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (as successor to The Chase Manhattan Bank, N.A.), AS TRUSTEE FIRST SUPPLEMENTAL INDENTURE Dated as of May 18, 2017 To the Indenture dated as of December 1, 1996 6.700% Notes due 2026 TA

EX-4.2 Exhibit 4.2 C. R. BARD, INC. and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (as successor to The Chase Manhattan Bank, N.A.), AS TRUSTEE FIRST SUPPLEMENTAL INDENTURE Dated as of May 18, 2017 To the Indenture dated as of December 1, 1996 6.700% Notes due 2026 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 2 Section 1.1 Definitions 2 ARTICLE 2 AMENDMENTS 2 Section 2.1 Certain Amendments to

C. R. BARD, INC. WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE FOURTH SUPPLEMENTAL INDENTURE Dated as of May 18, 2017 To the Indenture dated as of December 20, 2010 4.400% Notes due 2021 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 2 Section 1.1

EX-4.1 Exhibit 4.1 C. R. BARD, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, AS TRUSTEE FOURTH SUPPLEMENTAL INDENTURE Dated as of May 18, 2017 To the Indenture dated as of December 20, 2010 4.400% Notes due 2021 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 2 Section 1.1 Definitions 2 ARTICLE 2 AMENDMENTS 2 Section 2.1 Certain Amendments to the Indenture 2 ARTICLE 3 EFFECTIVENESS 3 Section 3.1 E

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commission

C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2016 to December 31, 2016

EX-1.01 Exhibit 1.01 C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2016 to December 31, 2016 This Conflict Minerals Report (the ?Report?) of C. R. Bard, Inc. (the ?Company?) has been prepared in accordance with Rule 13p-1 and Form SD (together, the ?Rule?) promulgated under Section 13(p) of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), f

Bard (C.R.) FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT C. R. Bard, Inc. (Exact Name of Registrant as Specified in Charter) New Jersey 1-6926 22-1454160 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 730 Central Avenue, Murray Hill, NJ 07974 (Address of Principal Executive Offices) (

Becton, Dickinson FORM 425 (Prospectus)

FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 SUBJECT COMPANY: C.

Bard (C.R.) FORM 425 (Prospectus)

Form 425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 On April 27, 2017, C. R. Bard, Inc. (“Bard”) made the following presentation available to employees of Bard in connection with Becton, Dickinson and Company’s pending acquisition

Bard (C.R.) FORM 425 (Prospectus)

Form 425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 On April 27, 2017, C. R. Bard, Inc. (?Bard?) made the following presentation available to employees of Bard in connection with Becton, Dickinson and Company?s pending acquisition

Bard (C.R.) FORM 10-Q (Quarterly Report)

Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

2005 DIRECTORS’ STOCK AWARD PLAN C. R. BARD, INC. (AS AMENDED AND RESTATED)

EX-10.45 Exhibit 10.45 2005 DIRECTORS? STOCK AWARD PLAN OF C. R. BARD, INC. (AS AMENDED AND RESTATED) Effective as of December 11, 2013, the 2005 Directors? Stock Award Plan of C. R. Bard, Inc. (the ?Plan?) is hereby amended and restated by C. R. Bard, Inc., a New Jersey corporation (the ?Corporation?), as set forth herein. The Corporation?s objectives in maintaining the Plan are (a) to attract an

STOCK EQUIVALENT PLAN FOR OUTSIDE DIRECTORS OF C. R. BARD, INC. (AS AMENDED AND RESTATED)

EX-10.44 Exhibit 10.44 STOCK EQUIVALENT PLAN FOR OUTSIDE DIRECTORS OF C. R. BARD, INC. (AS AMENDED AND RESTATED) C. R. Bard, Inc. hereby amends and restates the Stock Equivalent Plan for Outside Directors of C. R. Bard, Inc. (the ?Plan?). The Corporation?s objectives in maintaining the Plan are (a) providing a means of attracting and retaining Outside Directors whose abilities, experience and judg

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Three Months Ended March 31, 2017 Years Ended December 31, 2016 2015 2014 2013 2012 (dollars in millions) Earnings from operations before taxes $ 201.5 $ 663.7 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 Add (Deduct): Fixed charges 17.3 63.2 52.8 52.9 52.4 46.1 Undistributed earnings of eq

Bard (C.R.) FORM 425 (Prospectus)

Form 425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 C. R. Bard, Inc. (?Bard?) made the following presentation available to employees of Bard in connection with Becton, Dickinson and Company?s pending acquisition of Bard. Overview

Bard (C.R.) FORM 425 (Prospectus)

Form 425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 On April 27, 2017, C. R. Bard, Inc. (?Bard?) made the following slides available to employees of Bard in connection with Becton, Dickinson and Company?s pending acquisition of Ba

Becton, Dickinson 425 (Prospectus)

425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 SUBJECT COMPANY: C.

Bard (C.R.) FORM 425 (Prospectus)

Form 425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 On April 24, 2017 at 1:00pm (EST), C. R. Bard, Inc. (?Bard?) held a conference call with employees of Bard to provide supplemental information about the merger of Becton, Dickins

Becton, Dickinson 425 (Prospectus)

425 1 d383189d425.htm 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 UNDER THE SECURITIES AND EXCHANGE ACT OF 1934 SUBJECT COMPANY: C.R. BARD, INC. SEC FILE NO.: 001-06926 DATE: APRIL 24, 2017 On April 24, 2017, Becton, Dickinson and Company (“BD”) hosted a conference call to provide supplemental information

Bard (C.R.) 425 (Prospectus)

425 1 d346559d425.htm 425 Filer: C. R. Bard, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Exchange Act of 1934 Subject Company: C. R. Bard, Inc. Commission File No. 001-6926 On April 23, 2017, Becton, Dickinson and Company (“BD”) and C. R. Bard, Inc. (“Bard”) made available a transaction website at http://bdandbard.transactionannounc

1 TOM POLEN: We both improve fundamental processes in the healthcare system, lowering costs and improving quality of things like the medication management process, the infection prevention process, while at the same time making a substantial impact i

EX-99.5 Exhibit 99.5 SLATE: B.D. BARD VINCE FORLENZA: Today, we?re announcing the exciting combination of B.D. and Bard to build a leading healthcare company. A company that?s gonna be really impactful in advancing the world of health. TIM RING: This provides one of the largest medical device companies in the world that probably has the broadest array of products to take care of patients. VINCE FO

IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, Becton Dickinson and Company (“BD”) will file with the SEC a registration statement on Form S−4 that will constitute a prospectus of BD and include a proxy statement of

EX-99.6 WE BELIEVE We have a POWERFUL OPPORTUNITY to make healthcare BETTER TOGETHER. April 24, 2017 Exhibit 99.6 IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, Becton Dickinson and Company (?BD?) will file with the SEC a registration statement on Form S?4 that will constitute a prospectus of BD and include a proxy statement of C.R. Bard, Inc. (?Bard?). BD and Bar

BARD ANNOUNCES FIRST QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FIRST QUARTER RESULTS MURRAY HILL, NJ ? (April 23, 2017) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2017 first quarter financial results, prior to their previously communicated schedule. The

Agreement and Plan of Merger, dated as of April 23, 2017, as amended, by and among C. R. Bard, Inc., Becton, Dickinson and Company and Lambda Corp. (incorporated by reference to Exhibit 2.1 to Bard’s Current Report on Form 8-K filed on April 24, 2017)

EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER dated as of April 23, 2017 among C. R. BARD, INC., BECTON, DICKINSON AND COMPANY and LAMBDA CORP. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 20 Article 2 THE MERGER; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATES Section 2.01 The Merger 20 S

Email (Bard)

EX-99.3 Exhibit 99.3 All-Employee Email (Bard) SUBJECT: BD to Acquire C. R. Bard, Inc. Today, BD has announced its intention to acquire C. R. Bard, Inc., which will join two of the most established and respected healthcare organizations in the world into a customer-centric provider of complete healthcare solutions. As you know, Bard has been experiencing strong growth in recent years as we have st

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commissi

FORWARD-LOOKING STATEMENTS The information presented herein contains estimates and other forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The words “expect,” “anticipate,” “intend,” “plan,” “

EX-99.4 + Exhibit 99.4 FORWARD-LOOKING STATEMENTS The information presented herein contains estimates and other forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The words ?expect,? ?anticipate,? ?intend,? ?plan,? ?believe,? ?seek,? ?estimate,? ?outlook? and similar words, phrases or expressions are intended to identify such forward-looking

Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Wil

EX-99.2 Exhibit 99.2 Press Release BD To Acquire Bard For $24 Billion Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD?s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially C

IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, Becton Dickinson and Company (“BD”) will file with the SEC a registration statement on Form S−4 that will constitute a prospectus of BD and include a proxy statement of

EX-99.6 WE BELIEVE We have a POWERFUL OPPORTUNITY to make healthcare BETTER TOGETHER. April 24, 2017 Exhibit 99.6 IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, Becton Dickinson and Company (?BD?) will file with the SEC a registration statement on Form S?4 that will constitute a prospectus of BD and include a proxy statement of C.R. Bard, Inc. (?Bard?). BD and Bar

BARD ANNOUNCES FIRST QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FIRST QUARTER RESULTS MURRAY HILL, NJ ? (April 23, 2017) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2017 first quarter financial results, prior to their previously communicated schedule. The

Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Wil

EX-99.2 Exhibit 99.2 Press Release BD To Acquire Bard For $24 Billion Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially C

AGREEMENT AND PLAN OF MERGER dated as of April 23, 2017 C. R. BARD, INC., BECTON, DICKINSON AND COMPANY LAMBDA CORP. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 20 A

EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER dated as of April 23, 2017 among C. R. BARD, INC., BECTON, DICKINSON AND COMPANY and LAMBDA CORP. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 20 Article 2 THE MERGER; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATES Section 2.01 The Merger 20 S

Email (Bard)

EX-99.3 5 d346289dex993.htm EX-99.3 Exhibit 99.3 All-Employee Email (Bard) SUBJECT: BD to Acquire C. R. Bard, Inc. Today, BD has announced its intention to acquire C. R. Bard, Inc., which will join two of the most established and respected healthcare organizations in the world into a customer-centric provider of complete healthcare solutions. As you know, Bard has been experiencing strong growth i

FORWARD-LOOKING STATEMENTS The information presented herein contains estimates and other forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The words “expect,” “anticipate,” “intend,” “plan,” “

EX-99.4 + Exhibit 99.4 FORWARD-LOOKING STATEMENTS The information presented herein contains estimates and other forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. The words ?expect,? ?anticipate,? ?intend,? ?plan,? ?believe,? ?seek,? ?estimate,? ?outlook? and similar words, phrases or expressions are intended to identify such forward-looking

Bard (C.R.) FORM 8-K (Prospectus)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2017 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commissi

1 TOM POLEN: We both improve fundamental processes in the healthcare system, lowering costs and improving quality of things like the medication management process, the infection prevention process, while at the same time making a substantial impact i

EX-99.5 Exhibit 99.5 SLATE: B.D. BARD VINCE FORLENZA: Today, we?re announcing the exciting combination of B.D. and Bard to build a leading healthcare company. A company that?s gonna be really impactful in advancing the world of health. TIM RING: This provides one of the largest medical device companies in the world that probably has the broadest array of products to take care of patients. VINCE FO

BD AND BARD TO CREATE HIGHLY DIFFERENTIATED MEDICAL TECHNOLOGY COMPANY Combination Will Deliver Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes FRANKLIN LAKES, NJ MURRAY HILL, NJ FOUNDED IN 1897 FOUNDED IN 1907 Leading globa

Exhibit 99.7 BD AND BARD TO CREATE HIGHLY DIFFERENTIATED MEDICAL TECHNOLOGY COMPANY Combination Will Deliver Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes FRANKLIN LAKES, NJ MURRAY HILL, NJ FOUNDED IN 1897 FOUNDED IN 1907 Leading global medical technology company with strong capabilities in strategic selling, informatics and solutions delivery Medical technology leader

Homepage headline

EX-99.4 Exhibit 99.4 Homepage headline - BD Announces Agreement to Acquire Bard Homepage subhead – Creates a highly differentiated medical technology company uniquely positioned to deliver innovative offerings and unmatched solutions for healthcare providers and patients. Article copy: Today, BD announced an agreement to acquire C. R. Bard, Inc., a medical technology leader in the fields of vascul

CITIGROUP GLOBAL MARKETS INC. 388 Greenwich Street New York, New York 10013

EX-10.1 Exhibit 10.1 EXECUTION VERSION CITIGROUP GLOBAL MARKETS INC. 388 Greenwich Street New York, New York 10013 PERSONAL AND CONFIDENTIAL April 23, 2017 Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, NJ 07417 Attention: Christopher Reidy Executive Vice President, Chief Financial Officer and Chief Administrative Officer Project Lambda Bridge Facility Commitment Letter Ladies and Ge

April 23, 2017

EX-99.3 Exhibit 99.3 April 23, 2017 Vince Forlenza Chairman and CEO This message has been sent to all associates BD Announces Agreement to Acquire Bard I am delighted to announce that we have signed an agreement to acquire Bard, a global industry leader highly regarded for their innovative, life-enhancing medical technologies. The combined company will be uniquely positioned to improve both the in

1

Exhibit 99.8 SLATE: B.D. BARD VINCE FORLENZA: Today, we?re announcing the exciting combination of B.D. and Bard to build a leading healthcare company. A company that?s gonna be really impactful in advancing the world of health. TIM RING: This provides one of the largest medical device companies in the world that probably has the broadest array of products to take care of patients. VINCE FORLENZA:

1

EX-99.6 Exhibit 99.6 E-mail to BD Suppliers/Vendors Dear Valued [Supplier/Vendor]: I am very pleased to share with you the exciting news that today we announced that we have signed an agreement to acquire Bard, a global industry leader highly regarded for their innovative, life-enhancing medical technologies. The combined company will be uniquely positioned to improve both the process of care and

to Customers/Distributors

EX-99.5 Exhibit 99.5 E-mail to Customers/Distributors Dear Valued [BD Customer/Healthcare Provider]: I am very pleased to share with you the exciting news that today we announced that we have signed an agreement to acquire Bard, a global industry leader highly regarded for their innovative, life-enhancing medical technologies. The combined company will be uniquely positioned to improve both the pr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): April 24, 2017 (April 23, 201

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): April 24, 2017 (April 23, 2017) BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other jurisdictio

IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, Becton Dickinson and Company (“BD”) will file with the SEC a registration statement on Form S−4 that will constitute a prospectus of BD and include a proxy statement of

EX-99.2 WE BELIEVE We have a POWERFUL OPPORTUNITY to make healthcare BETTER TOGETHER. April 24, 2017 Exhibit 99.2 IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, Becton Dickinson and Company (“BD”) will file with the SEC a registration statement on Form S−4 that will constitute a prospectus of BD and include a proxy statement of C.R. Bard, Inc. (“Bard”). BD and Bar

EX-99.9

Exhibit 99.9

AGREEMENT AND PLAN OF MERGER dated as of April 23, 2017 C. R. BARD, INC., BECTON, DICKINSON AND COMPANY LAMBDA CORP. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 20 A

EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER dated as of April 23, 2017 among C. R. BARD, INC., BECTON, DICKINSON AND COMPANY and LAMBDA CORP. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 20 Article 2 THE MERGER; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATES Section 2.01 The Merger 20 S

Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Wil

EX-99.1 Exhibit 99.1 Press Release BD To Acquire Bard For $24 Billion Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially C

Becton, Dickinson and Company

Exhibit 99.10 Becton, Dickinson and Company On April 23, 2017, the following communications were made available by Becton, Dickinson and Company on Twitter, Facebook and LinkedIn: Twitter BD announces proposed acquisition of Bard to create highly differentiated medical technology company bdandbard.transactionannouncement.com Facebook Exciting news: BD is thrilled to announce the proposed acquisiti

BY-LAWS BECTON, DICKINSON AND COMPANY A New Jersey Corporation as Amended as of April 23, 2017 ARTICLE I

EX-3.1 Exhibit 3.1 BY-LAWS of BECTON, DICKINSON AND COMPANY A New Jersey Corporation as Amended as of April 23, 2017 ARTICLE I Offices The registered office of Becton, Dickinson and Company (the “Company”) shall be in the Borough of Franklin Lakes, County of Bergen, State of New Jersey or such other place within or without the State of New Jersey as the Board of Directors may designate. The Compan

Submission of Matters to a Vote of Security Holders

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 19, 2017 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Bard (C.R.) SCHEDULE 14A

Schedule 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Bard (C.R.) FORM 11-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K ☒ ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ☐ TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 1-6926 A. Full title of the plan and the address of the plan, i

Exhibit 12.1

EX-12.1 Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges (dollars in millions) 2016 2015 2014 2013 2012 Earnings from operations before taxes $ 663.7 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 Add (Deduct): Fixed charges 63.2 52.8 52.9 52.4 46.1 Undistributed earnings of equity investments — 0.4 0.3 (1.0 ) (9.6 ) Earnings available for fixed charges $ 726.9 $ 402.6 $ 499.0 $ 1,264.8 $ 768.9

AMENDMENT NO. 4 Dated as of November 22, 2016 CREDIT AGREEMENT Dated as of October 12, 2011

EX-10.43 Exhibit 10.43 EXECUTION COPY AMENDMENT NO. 4 Dated as of November 22, 2016 to CREDIT AGREEMENT Dated as of October 12, 2011 THIS AMENDMENT NO. 4 (this “Amendment”) is made as of November 22, 2016 by and among C. R. Bard, Inc., a New Jersey corporation (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (t

21-1

EX-21 4 d298442dex21.htm EX-21 Exhibit 21 Subsidiaries of the Registrant The following table lists, as of December 31, 2016, the company and its significant subsidiaries and indicates the jurisdiction of organization of each subsidiary: Where Incorporated C. R. Bard, Inc. (Registrant) New Jersey Bard Access Systems, Inc. Utah Bard Acquisition Sub, Inc. Delaware Bard ASDI, Inc. New Jersey Bard Aust

BCR / Bard (C.R.), Inc. 10-K - Annual Report - FORM 10-K

Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

BCR / Bard (C.R.), Inc. / VANGUARD GROUP INC Passive Investment

crbardinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: CR Bard Inc Title of Class of Securities: Common Stock CUSIP Number: 067383109 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate t

BARD ANNOUNCES FOURTH QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FOURTH QUARTER RESULTS MURRAY HILL, NJ ? (January 26, 2017) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2016 fourth quarter financial results. Fourth quarter 2016 net sales were $967.1 millio

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 26, 2017 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissi

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

8-K 1 d316525d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 22, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or O

BY-LAWS C. R. BARD, INC. (A New Jersey Corporation) (Amended and Restated December 22, 2016) ARTICLE I

EX-3.1 Exhibit 3.1 BY-LAWS of C. R. BARD, INC. (A New Jersey Corporation) (Amended and Restated December 22, 2016) ARTICLE I OFFICES The principal office of the Corporation shall be in the Borough of New Providence, County of Union, State of New Jersey. The Corporation may also establish and have such other offices as needed for the conduct of its business at such other place or places within or w

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 22, 2016 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commi

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Nine Months Ended September 30, 2016 Years Ended December 31, 2015 2014 2013 2012 2011 (dollars in millions) Earnings from operations before taxes $ 462.8 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 Add (Deduct): Fixed charges 45.5 52.8 52.9 52.4 46.1 42.7 Undistributed earnings of

BCR / Bard (C.R.), Inc. 10-Q - Quarterly Report - FORM 10-Q

Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

BARD ANNOUNCES THIRD QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES THIRD QUARTER RESULTS MURRAY HILL, NJ ? (October 25, 2016) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2016 third quarter financial results. Third quarter 2016 net sales were $941.9 million,

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 d227140d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Or

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 d274997d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 18, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Or

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Six Months Ended June 30, 2016 Years Ended December 31, 2015 2014 2013 2012 2011 (dollars in millions) Earnings from operations before taxes $ 350.6 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 Add (Deduct): Fixed charges 28.7 52.8 52.9 52.4 46.1 42.7 Undistributed earnings of equit

BCR / Bard (C.R.), Inc. 10-Q - Quarterly Report - FORM 10-Q

Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Financial Statements and Exhibits, Results of Operations and Financial Condition

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 26, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission File Numb

BARD ANNOUNCES SECOND QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES SECOND QUARTER RESULTS MURRAY HILL, NJ ? (July 26, 2016) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2016 second quarter financial results. Second quarter 2016 net sales were $931.5 million,

Bard (C.R.) FORM 11-K

FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-6926 A.

BCR / Bard (C.R.), Inc. / VANGUARD GROUP INC Passive Investment

SC 13G/A 1 crbardincamd5.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: CR Bard Inc Title of Class of Securities: Common Stock CUSIP Number: 067383109 Date of Event Which Requires Filing of this Statement: May 31, 2016 Check the appropriate box to designate the rule pursuant to which this Sche

Bard (C.R.) FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT C. R. Bard, Inc. (Exact Name of Registrant as Specified in Charter) New Jersey 1-6926 22-1454160 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 730 Central Avenue, Murray Hill, NJ 07974 (Address of Principal Executive Offices) (

C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2015 to December 31, 2015

EX-1.01 Exhibit 1.01 C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2015 to December 31, 2015 This Conflict Minerals Report (the ?Report?) of C. R. Bard, Inc. (the ?Company?) has been prepared in accordance with Rule 13p-1 and Form SD (together, the ?Rule?) promulgated under Section 13(p) of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?), f

THIRD SUPPLEMENTAL INDENTURE Dated as of May 9, 2016 Dated as of December 20, 2010 C. R. BARD, INC., as Issuer WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 3.000% Notes due 2026 TABLE OF CONTENTS

EX-4.1 Exhibit 4.1 THIRD SUPPLEMENTAL INDENTURE Dated as of May 9, 2016 to INDENTURE Dated as of December 20, 2010 Between C. R. BARD, INC., as Issuer and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 3.000% Notes due 2026 TABLE OF CONTENTS Page ARTICLE 1. DEFINITIONS 2 Section 1.1. Definition of Terms 2 Section 1.2. Additional Defined Terms 2 ARTICLE 2. TERMS AND CONDITIONS OF NOTES 6 Sectio

C. R. Bard, Inc. $500,000,000 3.000% Notes due 2026 UNDERWRITING AGREEMENT May 4, 2016 Merrill Lynch, Pierce, Fenner & Smith Incorporated Barclays Capital Inc. J.P. Morgan Securities LLC Underwriting Agreement

EX-1.1 Exhibit 1.1 C. R. Bard, Inc. $500,000,000 3.000% Notes due 2026 UNDERWRITING AGREEMENT May 4, 2016 Merrill Lynch, Pierce, Fenner & Smith Incorporated Barclays Capital Inc. J.P. Morgan Securities LLC Underwriting Agreement May 4, 2016 MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BARCLAYS CAPITAL INC. J.P. MORGAN SECURITIES LLC As Representatives of the several Underwriters c/o J.P. Mor

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2016 C. R. Bard, Inc. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization)

$500,000,000 C. R. Bard, Inc. 3.000% Notes due 2026

424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No.

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2016 C. R. Bard, Inc. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissi

Subject to Completion, dated May 4, 2016

424B5 1 d188607d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-210992 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they are not soliciting an offer to buy these securities in any jurisdiction w

C. R. Bard, Inc. Pricing Term Sheet May 4, 2016 U.S. $500,000,000 3.000% Senior Notes due 2026 Issuer: C. R. Bard, Inc. Legal Format: SEC Registered Size: $500 million aggregate principal amount of 3.000% notes due 2026 (the “notes”) Expected Ratings

FWP Free Writing Prospectus, dated May 4, 2016 Filed pursuant to Rule 433 under the Securities Act of 1933 Registration No.

Bard (C.R.) S-3ASR

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on April 29, 2016 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A N

BCR / Bard (C.R.), Inc. 10-Q - Quarterly Report - FORM 10-Q

Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Three Months Ended March 31, 2016 Years Ended December 31, 2015 2014 2013 2012 2011 (dollars in millions) Earnings from operations before taxes $ 142.9 $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 Add (Deduct): Fixed charges 13.3 52.8 52.9 52.4 46.1 42.7 Undistributed earnings of eq

BARD ANNOUNCES FIRST QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FIRST QUARTER RESULTS MURRAY HILL, NJ ? (April 27, 2016) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2016 first quarter financial results. First quarter 2016 net sales were $873.5 million, an

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 27, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 20, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Bard (C.R.) FORM 11-K

FORM 11-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or ? TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 1-6926 A. Full title of the plan and the address of t

Bard (C.R.) SCHEDULE 14A

DEF 14A 1 d127097ddef14a.htm SCHEDULE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check

AMENDMENT NO. 3 Dated as of November 23, 2015 CREDIT AGREEMENT Dated as of October 12, 2011

EX-10.42 Exhibit 10.42 EXECUTION COPY AMENDMENT NO. 3 Dated as of November 23, 2015 to CREDIT AGREEMENT Dated as of October 12, 2011 THIS AMENDMENT NO. 3 (this “Amendment”) is made as of November 23, 2015 by and among C. R. Bard, Inc., a New Jersey corporation (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (t

21-1

EX-21 4 d91981dex21.htm EX-21 Exhibit 21 Subsidiaries of the Registrant The following table lists, as of December 31, 2015, the company and its significant subsidiaries and indicates the jurisdiction of organization of each subsidiary: Where Incorporated C. R. Bard, Inc. (Registrant) New Jersey Bard Access Systems, Inc. Utah Bard Acquisition Sub, Inc. Delaware Bard ASDI, Inc. New Jersey Bard Austr

Exhibit 12.1

EX-12.1 Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges (dollars in millions) 2015 2014 2013 2012 2011 Earnings from operations before taxes $ 349.4 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 Add (Deduct): Fixed charges 52.8 52.9 52.4 46.1 42.7 Undistributed earnings of equity investments 0.4 0.3 (1.0 ) (9.6 ) (3.8 ) Earnings available for fixed charges $ 402.6 $ 499.0 $ 1,264.8 $ 768.9 $

BCR / Bard (C.R.), Inc. 10-K - Annual Report - FORM 10-K

Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

BCR / Bard (C.R.), Inc. / VANGUARD GROUP INC Passive Investment

crbardinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: CR Bard Inc Title of Class of Securities: Common Stock CUSIP Number: 067383109 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to designate t

BCR / Bard (C.R.), Inc. / YACKTMAN ASSET MANAGEMENT LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* C. R. Bard, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 067383109 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu

Financial Statements and Exhibits, Results of Operations and Financial Condition

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 28, 2016 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission File N

BARD ANNOUNCES FOURTH QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FOURTH QUARTER RESULTS MURRAY HILL, NJ ? (January 28, 2016) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2015 fourth quarter financial results. Fourth quarter 2015 net sales were $870.8 millio

LBMH / Liberator Medical Holdings, Inc. / BARD C R INC /NJ/ - SCHEDULE 13D AMENDMENT NO. 1 Activist Investment

Schedule 13D Amendment NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Liberator Medical Holdings, Inc. (Name of Issuer) Common Stock, $0.001 par value 53012L108 (Title of class of securities) (CUSIP number) Samrat S. Khichi, Esq. Senior Vice President, General Counsel and Secretary C. R. Bard,

Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 21, 2016 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commis

Liberator Medical Holdings SCHEDULE 13D (Activist Acquisition of More Than 5% of Shares)

Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 LIBERATOR MEDICAL HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 53012L108 (CUSIP Number) Samrat S. Khichi, Esq. Senior Vice President, General Counsel and Secretary C. R. Bard, Inc. 730 Central Avenue Murray Hill

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 d20289d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 23, 2015 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey (State or other jurisdiction of incorporation) 001-69

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission File Number 1-6926

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission File Number 1-6926 C. R. BARD, INC. (Exact name of registrant as specified in its charter) New Jersey 730 Central Avenue Murray Hill, New Jersey 07974

C. R. BARD, INC. AND SUBSIDIARIES

EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Nine Months Ended September 30, 2015 Years Ended December 31, 2014 2013 2012 2011 2010 (dollars in millions) Earnings from operations before taxes $ 191.4 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 Add (Deduct): Fixed charges 39.8 52.9 52.4 46.1 42.7 18.4 Undistributed earnings of equity

BARD ANNOUNCES THIRD QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES THIRD QUARTER RESULTS MURRAY HILL, NJ ? (October 22, 2015) ? C. R. Bard, Inc. (NYSE: BCR) today reported 2015 third quarter financial results. Third quarter 2015 net sales were $865.7 million,

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 d64753d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Org

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 13, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissi

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 5, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissio

Bard (C.R.) FORM S-8

S-8 1 d61763ds8.htm FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 C. R. BARD, INC. (Exact Name of Registrant as Specified in Its Charter) New Jersey 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 730 Central Avenue Murray Hill, New Jers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number 1-6926 C. R.

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number 1-6926 C. R. BARD, INC. (Exact name of registrant as specified in its charter) New Jersey 730 Central Avenue Murray Hill, New Jersey 07974 22-14

C. R. BARD, INC. AND SUBSIDIARIES

EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Six Months Ended June 30, 2015 Years Ended December 31, 2014 2013 2012 2011 2010 (dollars in millions) Earnings from operations before taxes $ 243.8 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 Add (Deduct): Fixed charges 26.6 52.9 52.4 46.1 42.7 18.4 Undistributed earnings of equity invest

C. R. BARD, INC. POWERS OF ATTORNEY

EX-24 Exhibit 24 C. R. BARD, INC. POWERS OF ATTORNEY KNOW ALL BY THESE PRESENTS, that each of the undersigned, being an officer or director, or both, of C. R. BARD, INC. (the ?Company?), in his or her capacity as set forth below, as applicable, hereby constitutes and appoints each of TIMOTHY M. RING and CHRISTOPHER S. HOLLAND, signing singly, as his or her true and lawful attorney and agent, to do

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

BARD ANNOUNCES SECOND QUARTER RESULTS

EX-99.1 2 d75432dex991.htm EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES SECOND QUARTER RESULTS MURRAY HILL, NJ — (July 23, 2015) — C. R. Bard, Inc. (NYSE: BCR) today reported 2015 second quarter financial results. Second quarter 2015 net

Other Events

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 14, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 18, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Clinical Design of the FIRST

EX-99.1 Clinical Design of the FIRST and ONLY Approved IDE BTK Trial for a Drug Coated Balloon Caution ? Investigational Device, Limited by Federal (USA) Law to Investigational Use Patrick Geraghty, MD, FACS Associate Professor of Surgery and Radiology Co-Director, Limb Preservation Center Washington University Medical School St. Louis, MO Exhibit 99.1 Disclaimer This presentation is on behalf of

Lutonix Global Real World SFA

EX-99.2 Lutonix Global Real World SFA Registry - Interim Results & First Look at LEVANT 2 24 Month Results Chad Laurich, MD Vascular Physician & Surgeon Sanford Health Sioux Falls, South Dakota Exhibit 99.2 Disclosures/Disclaimers ? The speaker?s presentation today is on behalf of Lutonix, Inc. Any discussion regarding Bard products during the presentation today is limited to information that is c

Bard (C.R.) FORM 11-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-6926 A.

C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2014 to December 31, 2014

EX-1.01 2 d934781dex101.htm EX-1.01 Exhibit 1.01 C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2014 to December 31, 2014 This Conflict Minerals Report (the “Report”) of C. R. Bard, Inc. (the “Company”) has been prepared in accordance with Rule 13p-1 and Form SD (together, the “Rule”) promulgated under Section 13(p) of the Securities Exchange Act of 1934, as ame

Bard (C.R.) FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT C. R. Bard, Inc. (Exact Name of Registrant as Specified in Charter) New Jersey 1-6926 22-1454160 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 730 Central Avenue, Murray Hill, NJ 07974 (Address of Principal Executive Offices) (

Other Events

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 1, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission Fi

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Three Months Years Ended December 31, Ended March 31, 2015 2014 2013 2012 2011 2010 (dollars in millions) Earnings from operations before taxes $ 184.6 $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 Add (Deduct): Fixed charges 13.3 52.9 52.4 46.1 42.7 18.4 Undistributed earnings of eq

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 Commission File Number 1-6926 C. R

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 Commission File Number 1-6926 C. R. BARD, INC. (Exact name of registrant as specified in its charter) New Jersey 730 Central Avenue Murray Hill, New Jersey 07974 22-1

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 23, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

BARD ANNOUNCES FIRST QUARTER RESULTS

EX-99.1 2 d914753dex991.htm EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FIRST QUARTER RESULTS MURRAY HILL, NJ — (April 23, 2015) — C. R. Bard, Inc. (NYSE: BCR) today reported 2015 first quarter financial results. First quarter 2015 net s

Description of the 2012 Long Term Incentive Plan of C. R. Bard, Inc., as amended and restated

EX-99.1 Exhibit 99.1 Description of the 2012 Long Term Incentive Plan of C. R. Bard, Inc., as amended and restated Administration. The 2012 Long Term Incentive Plan of C. R. Bard, Inc., as amended and restated (the ?Plan?) is administered by the Compensation Committee of the Board of Directors of C. R. Bard, Inc. (the ?Company?) or any subcommittee thereof, which is expected to consist of at least

2012 LONG TERM INCENTIVE PLAN C. R. BARD, INC. (AS AMENDED AND RESTATED)

EX-10.41 Exhibit 10.41 2012 LONG TERM INCENTIVE PLAN OF C. R. BARD, INC. (AS AMENDED AND RESTATED) Effective as of April 15, 2015, the 2012 Long Term Incentive Plan of C. R. Bard, Inc. is hereby amended and restated by C. R. Bard, Inc., a New Jersey corporation (the ?Corporation?), as set forth herein (the ?Plan?). The Plan was originally effective as of April 16, 2003. SECTION 1. ? Purpose of the

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 15, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Bard (C.R.) FORM 8-K (Current Report/Significant Event)

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 8, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

Bard (C.R.) FORM 11-K

Form 11-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 1-6926 A. Full title of the plan and the address of t

Bard (C.R.) SCHEDULE 14A

Schedule 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Exhibit 12.1

Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges (dollars in millions) 2014 2013 2012 2011 2010 Earnings from operations before taxes $ 445.8 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 Add (Deduct): Fixed charges 52.9 52.4 46.1 42.7 18.4 Undistributed earnings of equity investments 0.3 (1.0 ) (9.6 ) (3.8 ) (3.6 ) Earnings available for fixed charges $ 499.0 $ 1,264.8 $ 768.9 $ 549.7 $ 732.5

Incentive-Based Compensation Recovery (“Clawback”) Policy

EX-10.31 2 d817237dex1031.htm EX-10.31 Exhibit 10.31 Incentive-Based Compensation Recovery (“Clawback”) Policy The Board of Directors (the “Board”) of C. R. Bard, Inc. (the “Company”) has approved and adopted the following policy to define the terms pursuant to which the Company may recover incentive-based compensation from certain executives under the circumstances outlined below. With respect to

21-1

Exhibit 21 Subsidiaries of the Registrant The following table lists, as of December 31, 2014, the company and its significant subsidiaries and indicates the jurisdiction of organization of each subsidiary and the percentage of voting securities owned by the immediate parent of each subsidiary: Where Incorporated % of Voting Stock C.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 1-6926 C. R. BARD, INC. (Exact name of registrant as

AMENDMENT NO. 2 Dated as of November 18, 2014 CREDIT AGREEMENT Dated as of October 12, 2011

Exhibit 10.40 EXECUTION COPY AMENDMENT NO. 2 Dated as of November 18, 2014 to CREDIT AGREEMENT Dated as of October 12, 2011 THIS AMENDMENT NO. 2 (this ?Amendment?) is made as of November 18, 2014 by and among C. R. Bard, Inc., a New Jersey corporation (the ?Borrower?), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the ?Admin

BCR / Bard (C.R.), Inc. / VANGUARD GROUP INC Passive Investment

crbardinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: CR Bard Inc Title of Class of Securities: Common Stock CUSIP Number: 067383109 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to designate t

BCR / Bard (C.R.), Inc. / YACKTMAN ASSET MANAGEMENT LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* C. R. Bard, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 067383109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu

BARD ANNOUNCES FOURTH QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FOURTH QUARTER RESULTS MURRAY HILL, NJ - (January 29, 2015) - C. R. Bard, Inc. (NYSE: BCR) today reported 2014 fourth quarter financial results. Fourth quarter 2014 net sales were $867.2 millio

Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 29, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissi

Other Events

8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 13, 2015 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission Fi

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 18, 2014 C. R. Bard, Inc. (Exact name of registrant as specified in its charter) New Jersey 001-6926 22-1454160 (State or other jurisdiction of incorporation) (Commi

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Nine Months Years Ended December 31, Ended September 30, 2014 2013 2012 2011 2010 2009 (dollars in millions) Earnings from operations before taxes $ 271.1 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 $ 671.5 Add (Deduct): Fixed charges 39.2 52.4 46.1 42.7 18.4 17.5 Undistributed earnings of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 Commission File Number 1-6926

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 Commission File Number 1-6926 C. R. BARD, INC. (Exact name of registrant as specified in its charter) New Jersey 730 Central Avenue Murray Hill, New Jersey 07974

Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2014 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissi

BARD ANNOUNCES THIRD QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES THIRD QUARTER RESULTS MURRAY HILL, NJ — (October 22, 2014) — C. R. Bard, Inc. (NYSE: BCR) today reported 2014 third quarter financial results. Third quarter 2014 net sales were $830.0 million,

C. R. BARD, INC. POWERS OF ATTORNEY

EX-24 Exhibit 24 C. R. BARD, INC. POWERS OF ATTORNEY KNOW ALL BY THESE PRESENTS, that each of the undersigned, being an officer or director, or both, of C. R. BARD, INC. (the “Company”), in his or her capacity as set forth below, as applicable, hereby constitutes and appoints each of TIMOTHY M. RING and CHRISTOPHER S. HOLLAND, signing singly, as his or her true and lawful attorney and agent, to do

BCR / Bard (C.R.), Inc. S-8 - - FORM S-8

S-8 1 d767874ds8.htm FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 C. R. BARD, INC. (Exact Name of Registrant as Specified in Its Charter) New Jersey 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 730 Central Avenue Murray Hill, New Jer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 Commission File Number 1-6926 C. R.

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 Commission File Number 1-6926 C. R. BARD, INC. (Exact name of registrant as specified in its charter) New Jersey 730 Central Avenue Murray Hill, New Jersey 07974 22-14

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Six Months Ended June 30, 2014 Years Ended December 31, 2013 2012 2011 2010 2009 (dollars in millions) Earnings from operations before taxes $ 90.8 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 $ 671.5 Add (Deduct): Fixed charges 26.1 52.4 46.1 42.7 18.4 17.5 Undistributed earnings of equity

Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2014 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

BARD ANNOUNCES SECOND QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES SECOND QUARTER RESULTS MURRAY HILL, NJ — (July 24, 2014) — C. R. Bard, Inc. (NYSE: BCR) today reported 2014 second quarter financial results. Second quarter 2014 net sales were $827.1 million,

-

Response Letter VIA EDGAR June 23, 2014 Mr. Brian R. Cascio Accounting Branch Chief Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 RE: Form 10-K for the fiscal year ended December 31, 2013, filed February 19, 2014 File No. 001-06926 Dear Mr. Cascio: This letter is in response to the comment letter from the staff (the “Staff”) of the Securities and Exchange Commission

- FORM 11-K

Form 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 001-6926 A.

C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2013 to December 31, 2013

EX-1.02 Exhibit 1.02 C. R. Bard, Inc. Conflict Minerals Report For the Reporting Period from January 1, 2013 to December 31, 2013 This Conflict Minerals Report (the “Report”) of C. R. Bard, Inc. (the “Company”) has been prepared in accordance with Rule 13p-1 and Form SD (together, the “Rule”) promulgated under Section 13(p) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), f

-

CORRESP 1 filename1.htm VIA EDGAR June 2, 2014 Mr. Brian R. Cascio Accounting Branch Chief Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 RE: Form 10-K for the fiscal year ended December 31, 2013, filed February 19, 2014 File No. 001-06926 Dear Mr. Cascio: Reference is made to the comment letter from the staff (the “Staff”) of the Securities and Exchange Commission (t

- FORM SD

FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form SD SPECIALIZED DISCLOSURE REPORT C. R. Bard, Inc. (Exact Name of Registrant as Specified in Charter) New Jersey 1-6926 22-1454160 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) 730 Central Avenue, Murray Hill, NJ 07974 (Address of Principal Executive Of

EXECUTIVE BONUS PLAN C. R. BARD, INC.

Exhibit 10.39 EXECUTIVE BONUS PLAN OF C. R. BARD, INC. C. R. Bard, Inc. hereby amends and restates the Executive Bonus Plan of C. R. Bard, Inc. (the ?Plan?) to provide for incentive compensation to designated employees. The Corporation?s objectives in maintaining the Plan are to (i) attract, retain and motivate the executives required to manage the Corporation; and (ii) promote the achievement of

C. R. BARD, INC. AND SUBSIDIARIES

EX-12.1 EXHIBIT 12.1 C. R. BARD, INC. AND SUBSIDIARIES Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges Three Months Ended March 31, 2014 Years Ended December 31, 2013 2012 2011 2010 2009 (dollars in millions) Earnings from operations before taxes $ 183.6 $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 $ 671.5 Add (Deduct): Fixed charges 13.0 52.4 46.1 42.7 18.4 17.5 Undistributed earnings of eq

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 Commission File Number 1-6926 C. R

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 Commission File Number 1-6926 C. R. BARD, INC. (Exact name of registrant as specified in its charter) New Jersey 730 Central Avenue Murray Hill, New Jersey 07974 22-1

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 22, 2014 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

BARD ANNOUNCES FIRST QUARTER RESULTS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FIRST QUARTER RESULTS MURRAY HILL, NJ — (April 22, 2014) — C. R. Bard, Inc. (NYSE: BCR) today reported 2014 first quarter financial results. First quarter 2014 net sales were $799.3 million, an

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 16, 2014 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commission

2012 LONG TERM INCENTIVE PLAN C. R. BARD, INC. (AS AMENDED AND RESTATED)

EX-10.38 2 d712720dex1038.htm EX-10.38 Exhibit 10.38 2012 LONG TERM INCENTIVE PLAN OF C. R. BARD, INC. (AS AMENDED AND RESTATED) Effective as of April 16, 2014, the 2012 Long Term Incentive Plan of C. R. Bard, Inc. is hereby amended and restated by C. R. Bard, Inc., a New Jersey corporation (the “Corporation”), as set forth herein (the “Plan”). The Plan was originally effective as of April 16, 200

Description of the 2012 Long Term Incentive Plan of C. R. Bard, Inc., as amended and restated

EX-99.1 Exhibit 99.1 Description of the 2012 Long Term Incentive Plan of C. R. Bard, Inc., as amended and restated Administration. The 2012 Long Term Incentive Plan of C. R. Bard, Inc., as amended and restated (the “Plan”) is administered by the Compensation Committee or any subcommittee thereof, which is expected to consist of at least two individuals who are intended to qualify as “non-employee

- DEFINITVE ADDITIONAL MATERIALS

DEFA14A 1 d705141ddefa14a.htm DEFINITVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check

- FORM 11-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No: 1-6926 A. Full title of the plan and the address of the plan, i

- DEFINITIVE PROXY STATEMENT

DEF 14A 1 d630272ddef14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant x Filed by a Party other than the Regis

BY-LAWS C. R. BARD, INC. (A New Jersey Corporation) (Amended and Restated February 12, 2014) ARTICLE I

EX-3.1 Exhibit 3.1 BY-LAWS of C. R. BARD, INC. (A New Jersey Corporation) (Amended and Restated February 12, 2014) ARTICLE I OFFICES The principal office of the Corporation shall be in the Borough of New Providence, County of Union, State of New Jersey. The Corporation may also establish and have such other offices as needed for the conduct of its business at such other place or places within or w

21-1 Where Incorporated % of Voting Stock Bard Istanbul Healthcare Limited Company Turkey 100 Bard Poland Sp. z.o.o. Poland 100 Bard Verwaltung GmbH (f/k/a Angiomed GmbH) Germany 100 Gamer Lasertechnik GmbH Germany 100 Bard Benelux N.V. Belgium 100 B

EX-21 Exhibit 21 Subsidiaries of the Registrant The following table lists, as of December 31, 2013, the company and its significant subsidiaries and indicates the jurisdiction of organization of each subsidiary and the percentage of voting securities owned by the immediate parent of each subsidiary: Where Incorporated % of Voting Stock C.

C. R. BARD, INC. 2012 LONG TERM INCENTIVE PLAN Stock Option Award Certificate Granted To: Grant Date: Employee Number: Options Granted: Business Group: Grant Number:

Exhibit 10.37 FORM OF STOCK OPTION AWARD CERTIFICATE C. R. BARD, INC. 2012 LONG TERM INCENTIVE PLAN Stock Option Award Certificate Granted To: Grant Date: Employee Number: Options Granted: Business Group: Grant Number: C. R. Bard, Inc., a New Jersey corporation (the ?Corporation?) hereby grants you a number of Stock Options (the ?Options?) under the 2012 Long Term Incentive Plan of C. R. Bard, Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K

Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

C. R. BARD, INC. 2012 LONG TERM INCENTIVE PLAN Restricted Stock Units Award Certificate Granted To: Grant Date: Employee Number: RSUs Granted: Business Group: Grant Number:

EX-10.36 2 d624566dex1036.htm EX-10.36 Exhibit 10.36 FORM OF RESTRICTED STOCK UNITS AWARD CERTIFICATE C. R. BARD, INC. 2012 LONG TERM INCENTIVE PLAN Restricted Stock Units Award Certificate Granted To: Grant Date: Employee Number: RSUs Granted: Business Group: Grant Number: C. R. Bard, Inc., a New Jersey corporation (the “Corporation”) hereby grants you a number of Restricted Stock Units (the “RSU

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

8-K 1 d678862d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2014 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or O

Exhibit 12.1

EX-12.1 Exhibit 12.1 - Computation of Ratio of Earnings to Fixed Charges (dollars in millions) 2013 2012 2011 2010 2009 Earnings from operations before taxes $ 1,213.4 $ 732.4 $ 510.8 $ 717.7 $ 671.5 Add (Deduct): Fixed charges 52.4 46.1 42.7 18.4 17.5 Undistributed earnings of equity investments (1.0 ) (9.6 ) (3.8 ) (3.6 ) (2.3 ) Earnings available for fixed charges $ 1,264.8 $ 768.9 $ 549.7 $ 73

BCR / Bard (C.R.), Inc. / VANGUARD GROUP INC Passive Investment

crbardinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: CR Bard Inc Title of Class of Securities: Common Stock CUSIP Number: 067383109 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to designate t

BCR / Bard (C.R.), Inc. / YACKTMAN ASSET MANAGEMENT LP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* C. R. Bard, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 067383109 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu

BARD ANNOUNCES FOURTH QUARTER RESULTS DILUTED EPS OF $8.28, $1.42 ON ADJUSTED BASIS

EX-99.1 Exhibit 99.1 Contacts: Investor Relations: Todd W. Garner Vice President, Investor Relations (908) 277-8065 Media Relations: Scott T. Lowry Vice President and Treasurer (908) 277-8365 BARD ANNOUNCES FOURTH QUARTER RESULTS DILUTED EPS OF $8.28, $1.42 ON ADJUSTED BASIS MURRAY HILL, NJ — (January 30, 2014) — C. R. Bard, Inc. (NYSE: BCR) today reported 2013 fourth quarter financial results. Fo

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 30, 2014 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or Organization) (Commissi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 d643225d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2013 C. R. BARD, INC. (Exact Name of Registrant as Specified in Charter) New Jersey 001-6926 22-1454160 (State or Other Jurisdiction of Incorporation or O